Novartis Bioventures Ltd

Overview

• HeadquartersD0¹

See how the biggest companies compare on our leaderboards

Corporate structure

Novartis Bioventures Ltd sits at the top of its group. 6 entities, 3 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (5 companies). Each entity in the chart links to its source.

Stakes it holds

Novartis Bioventures Ltd has told the SEC it owns more than 5% of 5 companies, latest first (Schedules 13D and 13G).

• Oculis Holding AGSC 13G/A Mar 13, 2023 to Feb 13, 2024²
• Annexon, Inc.SC 13G/A Feb 11, 2022³
• Bicycle Therapeutics (United Kingdom)SC 13G/A Feb 11, 2022⁴
• Forma Therapeutics Holdings, Inc.SC 13G/A Feb 11, 2022⁵
• Galera Therapeutics, Inc.SC 13G/A Feb 11, 2022⁶